Rebates judge pharmaceutical companies’ destiny

The rebate investigation on pharmaceutical companies has been strongly conducted, enough to share their destiny.

While the pharmaceutical industry has internally said the prosecution-inspected company P will get damages that will be unable to recover, the investigation over the company Y which are being inspected now is strongly conducted overall.

According to the industry concerned, while mo...